W
WAVEMAN · COMPANY
MGPI · Mgp Ingredients Inc
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

MGPI

MGP INGREDIENTS INC
WHOLESALE & RETAIL · WHOLESALE-BEER, WINE & DISTILLED ALCOHOLIC BEVERAGES · CIK 0000835011
CONGRESS · 1FORM 144 · 1☆ WATCH
INSIDER NET · 180D
-$1.7M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
1
FUNDS ADDED · QTR
85
13F, latest reported quarter
REVENUE GROWTH
-23.8%
XBRL, annual
NET MARGIN
-20.1%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$1.7M over 180 days
-$586.2K over 90 days · -$1.7M of it by a 10%+ holder
below 56% of Wholesale & Retail
CONGRESS
1 member bought in the last year
the lowest in Wholesale & Retail
FUNDS
85 funds added or opened last quarter
below 57% of Wholesale & Retail
REVENUE
-23.8% year over year
below 88% of Wholesale & Retail
MARGIN
-20.1% net margin
below 84% of Wholesale & Retail
BUYBACKS
$886.0K repurchased, FY to 2026-03-31
below 89% of Wholesale & Retail
SHORT
4.1% of shares outstanding short · 5.5 days to cover · settled 2026-07-31
more than 61% of Wholesale & Retail
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
85 funds added or opened positions in the latest 13F quarter, of 159 holders.
1 member of Congress reported buying it this year.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -41.2%
-41.2%12M
-45%-30%-15%+0%2025-092025-102025-122026-032026-052026-072026-09 2025-12-09 · Seaberg Karen sold $4.0M2025-12-10 · Seaberg Karen sold $803.4K2025-12-10 · Seaberg Karen sold $761.2K2025-12-08 · Seaberg Karen sold $717.3K2025-11-18 · Kaplan Caroline Lux sold $711.5K2025-11-19 · Kaplan Caroline Lux sold $695.1K2026-08-20 · Lux Paul S. sold $586.2K2026-05-27 · Kaplan Caroline Lux sold $545.4K2026-05-26 · Kaplan Caroline Lux sold $534.6K2025-12-10 · Seaberg Karen sold $478.9K2025-12-08 · Seaberg Karen sold $293.0K2025-12-09 · Seaberg Karen sold $290.1K2025-12-10 · Seaberg Karen sold $65.2K2025-12-09 · Seaberg Karen sold $59.4K2025-11-18 · Kaplan Caroline Lux sold $4.1K2025-11-19 · Kaplan Caroline Lux sold $3.3K2026-08-17 · Ann S. Lux 2005 Irrevocable Trust FBO Paul S. Lux dated September 16, 2005, Paul S. Lux, Sole Investment Trustee filed to sell $599.0K
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $1.7M sold by insiders over 180 days, 85 funds added last quarter, 1 Congress member(s) bought in 12 months, $599.0K in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, MGP INGREDIENTS INC insiders sold a net $1.7M of stock across 352 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Lux Paul S.
SELL
2026-08-20
33,000.0
$586.2K
Kaplan Caroline Lux
SELL
2026-05-27
30,000.0
$545.4K
Kaplan Caroline Lux
SELL
2026-05-26
30,000.0
$534.6K
Seaberg Karen
Director
SELL
2025-12-10
18,203.0
$478.9K
Seaberg Karen
Director
SELL
2025-12-10
31,056.0
$803.4K
352 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 347 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Integrated Wealth Concepts LLC
2,505,779.0 sh
$43.9M
BlackRock, Inc.
1,270,417.0 sh
$22.3M
FEDERATED HERMES, INC.
980,092.0 sh
$17.2M
PRIVATE MANAGEMENT GROUP INC
2,717,181.0 sh
$14.8M
VANGUARD CAPITAL MANAGEMENT LLC
643,437.0 sh
$11.3M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Ann S. Lux 2005 Irrevocable Trust FBO Paul S. Lux dated September 16, 2005, Paul S. Lux, Sole Investment Trustee
FILED 2026-08-17
$599.0K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Lord Abbett Convertible Fund
$26.9M POSITION · AS OF 2026-02-28
4.2%
Greenspring Income Opportunities Fund
$3.9M POSITION · AS OF 2026-03-31
1.0%
Federated Hermes MDT Small Cap Value Fund f/k/a Federated Hermes Clover Small Value Fund
$1.4M POSITION · AS OF 2026-03-31
0.9%
Federated Hermes MDT Small Cap Core ETF
$1.3M POSITION · AS OF 2026-02-28
0.8%
Acquirers Small and Micro Deep Value ETF
$201.4K POSITION · AS OF 2026-02-28
0.8%
Lazard Enhanced Opportunities Portfolio
$525.8K POSITION · AS OF 2026-03-31
0.7%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Clinical pipeline
ClinicalTrials.gov · 1 registered trials, 0 still enrolling or running — a status change here is dated weeks before the press release
1
Not applicable
0 ACTIVE
TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$536.4M$703.6M$836.5M$782.4M
GROSS PROFIT$199.4M$286.3M$304.7M$253.3M
OPERATING INCOME$-94.6M$74.4M$148.6M$149.0M
NET INCOME$-107.8M$34.5M$107.1M$108.9M
EPS (DILUTED)-4.991.564.804.92
OPERATING CASH FLOW$121.5M$102.3M$83.8M$88.9M
CASH$18.5M$25.3M$18.4M$47.9M
LONG-TERM DEBT$260.1M$329.4M$293.9M$29.5M
BUYBACKS$1.0M$48.8M$801.0K$715.0K
DIVIDENDS PAID$10.3M$10.6M$10.7M$10.6M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →